Connecticut’s Opioid Services Division, established in 2018, coordinates opioid use disorder treatment, recovery support and harm reduction programs. Through State Opioid Response grants and Opioid Settlement Advisory Committee funding, it has made real progress against Connecticut’s overdose crisis.
Another important measure, taken in 2022, was joining a federal Medicaid waiver program, which expanded HUSKY Health coverage across the full continuum of substance use care, from ambulatory withdrawal management to inpatient services.
Together, these programs, along with other critical interventions, contributed to a 26% decline in the number of overdose deaths between 2023 and 2024.
Despite this progress, gaps remain, particularly in residential care for adolescents with substance use disorder. The state has struggled to find Medicaid-enrolled providers willing to operate 24-hour residential programs for teens, even after DMHAS raised reimbursement rates in mid-2025.
Substance use treatment in Connecticut is overseen by the Department of Mental Health and Addiction Services (DMHAS), which licenses and funds detox, residential and outpatient programs statewide. DMHAS also co-chairs the state’s Alcohol and Drug Policy Council alongside the Department of Children and Families, coordinating substance use priorities across state agencies.
Anyone choosing a detox center in Connecticut can confirm a provider’s licensing status directly through DMHAS.
